LPCN CIK: 1535955

Lipocine Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.41
FY22:
−12.0
FY23:
−11.9
FY24:
−1.22
FY25:
−9.76
Change from FY21 to FY25
millions USD
FY21:
−43.8
FY22:
14.3
FY23:
13.1
FY24:
2.45
FY25:
5.89
Change from FY21 to FY25
millions USD
FY21:
26.9
FY22:
−2.13
FY23:
0.40
FY24:
0.21
FY25:
2.87
millions USD
FY21:
−21.3
FY22:
0.20
FY23:
1.62
FY24:
1.43
FY25:
−1.00
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.42
FY22:
−12.1
FY23:
−11.9
FY24:
−1.31
FY25:
−9.76

All amounts in millions USD Data sources:SEC EDGARTwelve Data